Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 370.05
+9.85 (2.73%)
At close: Jun 16, 2026
Gufic Biosciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 642.15 | 696.5 | 861.36 | 797.05 | 958.4 |
Depreciation & Amortization | 308.33 | 205.34 | 167.57 | 221.03 | 188.88 |
Other Amortization | - | 5.31 | 2.61 | 1.78 | 0.41 |
Loss (Gain) From Sale of Assets | 0.04 | -1.16 | 23 | -0.3 | -0.68 |
Stock-Based Compensation | - | 1.04 | - | - | - |
Other Operating Activities | 448.47 | 244.23 | 173.21 | 67.1 | 22.59 |
Change in Accounts Receivable | -235.94 | 73.66 | -1,532 | -553.16 | -231.93 |
Change in Inventory | -1,076 | -163.87 | -170.25 | -678.91 | -211.62 |
Change in Accounts Payable | 362.61 | 164.64 | 400.36 | -120.46 | 336.35 |
Operating Cash Flow | 449.68 | 1,226 | -74.57 | -265.87 | 1,062 |
Operating Cash Flow Growth | -63.31% | - | - | - | 21.76% |
Capital Expenditures | -311.81 | -755.26 | -1,127 | -1,876 | -874.53 |
Sale of Property, Plant & Equipment | 0.02 | 47.67 | 45.66 | 0.32 | 0.68 |
Cash Acquisitions | -0.61 | - | - | - | - |
Investment in Securities | - | - | -10 | -7.77 | - |
Other Investing Activities | 2.77 | -0.19 | 67.39 | -23.81 | -72.04 |
Investing Cash Flow | -309.64 | -707.77 | -1,024 | -1,907 | -945.89 |
Short-Term Debt Issued | 1,003 | 168.04 | 423.44 | 1,426 | - |
Long-Term Debt Issued | - | - | - | 1,075 | 119.71 |
Total Debt Issued | 1,003 | 168.04 | 423.44 | 2,501 | 119.71 |
Short-Term Debt Repaid | - | - | - | - | -60.78 |
Long-Term Debt Repaid | -340.44 | -321.27 | -457.62 | -66.19 | -61.87 |
Total Debt Repaid | -340.44 | -321.27 | -457.62 | -66.19 | -122.65 |
Net Debt Issued (Repaid) | 662.08 | -153.23 | -34.18 | 2,435 | -2.94 |
Issuance of Common Stock | 2.75 | - | 999.9 | - | - |
Common Dividends Paid | -10.03 | -10.03 | -9.72 | -10.44 | -9.21 |
Other Financing Activities | -330.19 | -208.78 | -132.19 | -81.22 | -50.29 |
Financing Cash Flow | 324.61 | -372.04 | 823.81 | 2,343 | -62.44 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 |
Net Cash Flow | 464.64 | 145.87 | -274.65 | 169.94 | 54.07 |
Free Cash Flow | 137.87 | 470.42 | -1,202 | -2,142 | 187.86 |
Free Cash Flow Growth | -70.69% | - | - | - | -74.90% |
Free Cash Flow Margin | 1.46% | 5.74% | -14.89% | -31.01% | 2.41% |
Free Cash Flow Per Share | 1.37 | 4.69 | -12.20 | -22.09 | 1.94 |
Cash Interest Paid | 328.06 | 208.78 | 126.59 | 79.06 | 48.09 |
Cash Income Tax Paid | 118.42 | 228.12 | 270.44 | 276.96 | 330.57 |
Levered Free Cash Flow | -339.67 | -80.69 | -1,421 | -2,332 | -151.59 |
Unlevered Free Cash Flow | -110.85 | 63.24 | -1,329 | -2,290 | -126.55 |
Change in Working Capital | -949.3 | 74.43 | -1,302 | -1,353 | -107.2 |